tiprankstipranks

John M. Leonard Insider Profile

18 Followers
John M. Leonard, President & CEO, Director at Intellia Therapeutics, holds 1.21M shares in Intellia Therapeutics (Ticker: NTLA), holds 16.95K shares in IQVIA Holdings (Ticker: IQV), holds 5.00K shares in Chimerix (Ticker: CMRX).
tipranks
John M. Leonard

John M. Leonard
Intellia Therapeutics (NTLA)
President & CEO, Director

Ranked #34,773 out of 108,814 Corporate Insiders

Profitable Transactions

71%
5 out of 7 Profitable Transactions

Average Return

+3.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$50M
60.00%
30.99%
9.01%
A breakdown of John M. Leonard's holdings

Insider Roles

AbbVie
(ABBV)
SVP, Chief Scientific Officer
Intellia Therapeutics
(NTLA)
President & CEO, Director
IQVIA Holdings
(IQV)
Director
Roles that John M. Leonard holds in companies

Most Profitable Insider Trade

Stock:
Intellia Therapeutics
(NTLA)
Rating:Informative Sell
Date:Jan 05, 2024 - Jan 05, 2025
Return:+57.60%
The most profitable trade made by John M. Leonard

John M. Leonard's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Intellia Therapeutics
Aug 24, 2026
President & CEO, Director
Uninformative Sell
286.82K
$15.38M
CMRX
Chimerix
Sep 16, 2016
Informative Sell
25.15K
$42.70K
IQVIA Holdings
Apr 27, 2026
Director
Uninformative Buy
$4.47M
VTAE
Vitae Pharma
$0.00
AbbVie
Mar 19, 2013
SVP, Chief Scientific Officer
Uninformative Sell
1.80M
$29.78M
List of latest transactions for each holding click on a transaction to see John M. Leonard's performance on stock

John M. Leonard insider profile FAQ

What is the percentage of profitable transactions made by John M. Leonard?
The percentage of profitable transactions made by John M. Leonard is 71%.
    What is the average return per transaction made by John M. Leonard?
    The average return per transaction made by John M. Leonard is 3.70%.
      What stocks does John M. Leonard hold?
      John M. Leonard holds: NTLA, CMRX, IQV, VTAE, ABBV stocks.
        What was John M. Leonard’s latest transaction?
        John M. Leonard latest transaction was an Uninformative Sell of $286.82K.
          What was John M. Leonard's most profitable transaction?
          John M. Leonard’s most profitable transaction was an Informative Sell of NTLA stock on January 5, 2024. The return on the trade was 57.60%.
            What is John M. Leonard's role in Intellia Therapeutics?
            John M. Leonard's role in Intellia Therapeutics is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.